Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study

doi:10.12998/wjcc.v11.i17.3993

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3074)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

144

WORD

104

HTML

1519

Figures (1-3)

381

Tables (1-4)

260

Sum=2408

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

163

Download

379

Sum=542

Jun 16, 2023 (publication date) through Dec 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Jun 16, 2023; 11(17): 3993-4002
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.3993

Full Size Figure Download Figure

Figure 1 Showing serum elabela across the study participants. PE: Preeclampsia.

Citation: Amer Ali E, Nori W, Salman AF, Al-Rawi TSS, Hameed BH, Al-Ani RM. Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study. World J Clin Cases 2023; 11(17): 3993-4002
URL: https://www.wjgnet.com/2307-8960/full/v11/i17/3993.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i17.3993